ICD-10-CM Billable Code

H11.239

Symblepharon, unspecified eye

Clinical Classification Guidelines

Medical Intelligence & Overview

Symblepharon is a condition where there is an abnormal adhesion between the conjunctiva (the thin, transparent tissue covering the white of the eye) and the eyelid. When this adhesion involves an unspecified eye, it can affect either the right or left eye, leading to problems with eye movement, comfort, and vision. This condition results from scarring and tissue changes that occur after ocular injuries, infections, or inflammatory diseases. Recognizing symblepharon is essential for proper management and to prevent further eye complications.

Causes & Symptoms

Clinical Causes: Trauma or injury to the eye, such as burns or lacerations Ocular infections, including viral or bacterial conjunctivitis Chronic ocular inflammation due to conditions like Stevens-Johnson syndrome Autoimmune disorders affecting the eye, such as ocular cicatricial pemphigoid Previous eye surgeries or radiation therapy Chemical burns or exposure to caustic substances

Key Symptoms: Restricted eye movement, leading to limited eyelid opening or gaze restriction Redness and irritation of the eye Persistent eye discomfort or a foreign body sensation Discharge or tearing from the affected eye Visual disturbances or blurriness in severe cases Formation of visible or palpable adhesions between the eyelid and eyeball

Diagnostic & Treatment

Diagnosis Path: Diagnosing symblepharon involves a comprehensive eye examination by an ophthalmologist. The specialist will inspect the eye for adhesions, scarring, and inflammation. Additional tests, such as slit-lamp microscopy, may be used to assess the extent of the adhesion and any associated ocular surface damage. Patient history regarding previous injuries, surgeries, or inflammatory conditions is also vital for diagnosis.

Treatment Protocols: Treatment aims to release the adhesions, restore normal ocular surface anatomy, and prevent recurrence. Approaches include: - **Medical management:** Use of topical corticosteroids or lubricants to reduce inflammation and promote healing. - **Surgical intervention:** Removal of adhesions through procedures like symblepharon lysis, often followed by reconstruction of the ocular surface with grafts or amniotic membrane transplantation. - **Postoperative care:** Use of immunosuppressive medications in cases related to autoimmune diseases, along with regular follow-up to prevent re-adhesion. Early detection and management are crucial to preserving ocular function and preventing more severe complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H11.239 a billable ICD-10 code?
Yes, H11.239 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H11.239?
Clinical documentation must specify the nature of Symblepharon, unspecified eye and any associated comorbidities for accurate reporting.

Cite this Clinical Reference